Business
MEDI: Growth to NOK 1 billion targeted via INTUI software, innovation, and global clinical validation
MEDI: Growth to NOK 1 billion targeted via INTUI software, innovation, and global clinical validation
About this update from Medistim Asa
Accelerated growth is expected through innovation, expanded direct market coverage, and the launch of the INTUI software platform, which modernizes surgical workflows and reporting. Clinical studies and new business models support broader adoption, while financial guidance targets NOK 1 billion in annual sales within a few years.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.